Azra AI vs Patients.app (2026)
Both read records to trigger action rather than to inform a reader, and they pick different high consequence moments. Azra watches pathology and radiology reports arrive and turns findings into assigned work for a navigator, which addresses patients lost between diagnosis and follow up. Patients.app screens records for surgical readiness, pulling in outside records so the assessment is made on the whole picture rather than on what happens to be in the local chart, with human structures downstream of the output. Both are useful and both share a blind spot: they publish what they surface and not what proportion of it was worth surfacing. Ask each for the actionable rate, because a system that generates fifty cases a week for a navigator who can work fifteen has not solved the problem, it has moved it.
- Both products are instrument level rather than generic, screening records for surgical readiness and for a second high consequence workflow rather than summarising charts in general.
- Every result links back to its source, and genuine human structures sit downstream of both products rather than the output going straight into a decision.
- It retrieves records from outside the organisation as part of the workflow, which is where the missing information for a surgical readiness decision usually lives.
- It converts findings in pathology and radiology reports into assigned work, which is an operational output rather than an informational one.
- The integration is live and deep, consuming interface feeds as reports land rather than running a periodic query.
- Coverage started in oncology across the whole service line and has broadened, so the workflow is proven on the hardest version of the problem.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Azra AI and Patients.app are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Azra AI | Patients.app |
|---|---|---|
| Primary category | Healthcare Administrative Automation | Clinical Summarization & Chart Review |
| Founded | 2022 | Not recorded |
| Headquarters | Nashville, Tennessee, United States | Not recorded |
| Website | azra-ai.com | patients.app |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Azra AI its top capability grade on EHR and Interoperability Depth. Set against Patients.app, Azra AI grades higher on Model Supply Chain Disclosure and EHR and Interoperability Depth. Its thinnest published disclosure sits on several axes, including HIPAA and BAA Posture, Security Certifications and Trust Center and AI Governance and Bias Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Patients.app its top capability grade on AI Centrality. Set against Azra AI, Patients.app grades higher on several axes, including AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Azra AI or Patients.app?
On the axes where the AI Health Index separates them, Azra AI grades higher on Model Supply Chain Disclosure and EHR and Interoperability Depth, and Patients.app grades higher on several axes, including AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. Patients.app leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Azra AI and Patients.app differ most?
The widest separation the AI Health Index records between Azra AI and Patients.app is on EHR and Interoperability Depth, where Azra AI grades A and Patients.app grades C. That axis sits in the Integration and Deployment group, so it should carry the most weight for a buyer whose binding constraint is how the product lands in the stack already in place.
Where do Azra AI and Patients.app grade the same?
The AI Health Index grades Azra AI and Patients.app the same on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Azra AI and Patients.app not disclosed?
At the last review, at least one of Azra AI and Patients.app published thin or absent detail on several axes, including Model Supply Chain Disclosure, HIPAA and BAA Posture and Security Certifications and Trust Center. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
Both products act on the assumption that acting sooner is better, and neither publishes the counterpart figure: what proportion of surfaced cases are actionable, and how much work is generated by cases that were not. Azra publishes no health privacy statement, business associate terms or security attestation despite consuming live clinical feeds.
Patients.app publishes no retention position or training use statement, and its efficiency claim of time saved per case is unaccompanied by any measure of what was missed. Neither publishes pricing or a subgroup performance analysis.